IBRX Market Cap & Key Metrics
ImmunityBio, Inc.
$10.04
+$0.13(+1.26%)
55
Overall
40
Value
75
Tech
50
Quality
Market Cap
$10.50B
Volume
13.37M
52W Range
$1.95 - $12.43
Target Price
$12.60
IBRX market cap is $10.50B. This page lists ImmunityBio, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
IBRX Key Metrics
- Market cap
- $10.50B
- EPS estimate, current year
- $-0.44
- EPS growth, 3-year
- +28.51%
- Value score
- 40
- Quality score
- 50
- Technical score
- 75
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $113.29M | $14.74M | $622.0K | $240.0K | $934.0K |
| EBITDA | -$284.54M | -$333.85M | -$516.79M | -$313.30M | -$320.75M |
| EPS | $-0.38 | $-0.59 | $-1.15 | $-1.04 | $-0.89 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IBRX | $10.04 | +1.3% | 13.37M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |